BioSpace News Archive

Drug Development

ASCO2016: Oncothyreon Presents Phase Ib Results Of ONT-380 In Combination With T-DM1 In HER2+ Metastatic Breast Cancer At ASCO

June 6, 2016
·
5 min read
Drug Development

ASCO2016: VBL Therapeutics VB-111 Clinical Data Presented At ASCO Demonstrate Significant Increase In Overall Survival In Platinum-Resistant Ovarian Cancer

June 6, 2016
·
6 min read
Drug Development

ASCO2016: NewLink Genetics Presents Clinical Data For IDO Pathway Inhibitor Indoximod Combinations At ASCO Annual Meeting

June 6, 2016
·
6 min read
Drug Development

ASCO2016: Cyclacel Pharmaceuticals, Inc. Reports Updated Data From Its DNA Damage Response Program On Seliciclib And Sapacitabine Combination In Patients With Solid Tumors At ASCO

June 6, 2016
·
9 min read
Drug Development

ASCO2016: NuCana Acelarin Achieves High Clinical Activity And Durable Disease Control In Patients With Recurrent Ovarian Cancer

June 6, 2016
·
3 min read
Policy

Clinical Leaders Reinforce Belief In NGAL For Detection Of AKI Following FDA’s Decision On BioPorto’s The NGAL Test

June 6, 2016
·
2 min read
Deals

H.B. Fuller Company Agrees To Acquire Cyberbond, L.L.C.

June 6, 2016
·
1 min read
Business

Alder Biopharma Appoints Roger Cady, M.D., Vice President Of Neurology

June 6, 2016
·
5 min read
Business

Hemispherx Obtains A Comprehensive Carter Omnibus Assignment Of Intellectual Property

June 6, 2016
·
5 min read
Forward Pharma CFO To Participate In Two Investor Conferences In June

June 6, 2016
·
3 min read